Literature DB >> 24558070

Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations.

Valerio Gallotta1, Francesco Fanfani, Anna Fagotti, Vito Chiantera, Francesco Legge, Salvatore Gueli Alletti, Camilla Nero, Alessandro Pasquale Margariti, Valerio Papa, Sergio Alfieri, Francesca Ciccarone, Giovanni Scambia, Gabriella Ferrandina.   

Abstract

BACKGROUND: The aim of this retrospective study was to investigate the incidence of mesenteric lymph node (MLN) involvement, and its prognostic role in advanced ovarian cancer (OC).
METHODS: OC patients undergoing rectosigmoid resection during primary debulking surgery or interval debulking surgery were recorded. Progression-free survival (PFS) and overall survival were calculated from the date of diagnosis to the date of relapse/progression, death of disease, or the date of last follow-up.
RESULTS: MLNs were detected in 102/148 cases (68.9 %); the rate of MLN involvement was 47.0 %. The percentage of metastatic MLNs was higher in cases with >5 MLNs removed compared with cases with ≤ 5 MLNs removed (62.7 % vs. 31.3 %; p = 0.0027). A progressive increase in the rate of metastatic MLNs was documented in association with depth of bowel infiltration (p = 0.026). Cases with metastatic MLNs experienced isolated celiac trunk or aortic lymph node recurrences more frequently than patients without MLN involvement (44.8 % vs. 10.7 %; p = 0.0008). PFS did not differ between cases with positive versus negative MLN involvement (2-year PFS = 31 % vs. 43 %; p = 0.58).
CONCLUSION: OC patients undergoing rectosigmoid resection showed metastatic MLN involvement in 47.0 % of cases. Metastatic MLN status is associated with a high rate of isolated aortic and celiac trunk lymph node recurrences.

Entities:  

Mesh:

Year:  2014        PMID: 24558070     DOI: 10.1245/s10434-014-3558-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Right Upper Abdominal Resections in Advanced Stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Camelia Diaconu; Laura Iliescu; Alexandru Filipescu; Irina Balescu; Cora Pop; Simona Dima; Mihaela Vilcu; Iulian Brezean
Journal:  In Vivo       Date:  2020-04-29       Impact factor: 2.155

2.  Clinical Significance of Mesenteric Lymph Node Involvement in the Pattern of Liver Metastasis in Patients with Ovarian Cancer.

Authors:  Kana Tanaka; Yoshifumi Shimada; Koji Nishino; Kosuke Yoshihara; Masato Nakano; Hitoshi Kameyama; Takayuki Enomoto; Toshifumi Wakai
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

3.  The Role of Indocyanine Near-Infrared Fluorescence in Colorectal Surgery.

Authors:  Francesco Maione; Michele Manigrasso; Alessia Chini; Sara Vertaldi; Pietro Anoldo; Anna D'Amore; Alessandra Marello; Carmen Sorrentino; Grazia Cantore; Rosa Maione; Nicola Gennarelli; Salvatore D'Angelo; Nicola D'Alesio; Giuseppe De Simone; Giuseppe Servillo; Marco Milone; Giovanni Domenico De Palma
Journal:  Front Surg       Date:  2022-05-20

4.  Ostomy Does Not Lead to Worse Outcomes After Bowel Resection With Ovarian Cancer: A Systematic Review.

Authors:  Xinlin He; Zhengyu Li
Journal:  Front Oncol       Date:  2022-05-23       Impact factor: 5.738

5.  Clinical Phenotypes of Tumors Invading the Rectosigmoid Colon Affecting the Extent of Debulking Surgery and Survival in Advanced Ovarian Cancer.

Authors:  Soo Jin Park; Jaehee Mun; Eun Ji Lee; Sunwoo Park; Sang Youn Kim; Whasun Lim; Gwonhwa Song; Jae-Weon Kim; Seungmee Lee; Hee Seung Kim
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

6.  Conditional Relative Survival of Ovarian Cancer: A Korean National Cancer Registry Study.

Authors:  Dong Wook Shin; Jaeman Bae; Johyun Ha; Kyu-Won Jung
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

7.  A Prediction Model for Optimal Primary Debulking Surgery Based on Preoperative Computed Tomography Scans and Clinical Factors in Patients With Advanced Ovarian Cancer: A Multicenter Retrospective Cohort Study.

Authors:  Yu Gu; Meng Qin; Ying Jin; Jing Zuo; Ning Li; Ce Bian; Yu Zhang; Rong Li; Yu-Mei Wu; Chun-Yan Wang; Ke-Qiang Zhang; Ying Yue; Ling-Ying Wu; Ling-Ya Pan
Journal:  Front Oncol       Date:  2021-01-07       Impact factor: 6.244

8.  Postoperative Intestinal Fistula in Primary Advanced Ovarian Cancer Surgery.

Authors:  Antoni Llueca; Anna Serra; Maria Teresa Climent; Karina Maiocchi; Alvaro Villarin; Katty Delgado; Josep Mari-Alexandre; Juan Gilabert-Estelles; Paula Carrasco; Blanca Segarra; Luis Gomez; Juan Jose Hidalgo; Javier Escrig; Manuel Laguna
Journal:  Cancer Manag Res       Date:  2021-01-06       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.